Optimism About Case Rates, Vaccines, And Futu...

So much has happened since ICE ramped up efforts in Minneapolis. It can be hard to get a sense of the big picture. Two NPR reporters on the ground do just that.It’s been nearly two months since ICE descended on the streets of Minneapolis. In that time, Renee Macklin Good has been ...  Show more

Scientists say research into a vaccine for HIV is further along than it’s ever been.But Trump administration cuts to scientific research have set that effort back.Including a promising trial for an HIV vaccine in Africa – which was shut down altogether.NPR’s Ari Daniel has the st ...  Show more

For six months, people across the country have been waiting for the same lifeline: a vaccine for the coronavirus. The U.S. government has pledged $10 billion to help drug makers develop and distribute a vaccine in record time through “Operation Warp Speed.”

But the emp ...

The coronavirus seems to be in retreat in the United States, with the number of cases across the country down about 25 percent compared with a couple of weeks ago. Hospitalizations and deaths are also falling.

So, what stage are we in with the pandemic? And how will deve ...

Vaccine hesitancy is a major reason that many experts now fear the United States will struggle to attain herd immunity against the coronavirus.

And while many initially hesitant demographics have become more open to vaccinations, one group is shifting much less: white Re ...

Nothing makes sense. “The Delta variant” canard doesn’t explain how the virus is now much worse than ever before when nearly every adult is vaccinated in a lot of areas getting hit hard. Today, we are joined by Dr. Lynn (pseudonym), associate medical director of America’s Frontli ...  Show more